Dexco (Diabete MedTech company) is delivering on its promisessteemCreated with Sketch.

in #dexcom • 5 years ago


Dexcom
broke $1B in revenue in 2018, plans to outsource some customer support (mobi
health news)

  • Continuous glucose monitoring (CGM) giant Dexcom recently reported Q4 2018 earnings, stating it broke USD1bn in annual revenue in 2018 while increasing adoption rates, and announcing outsourcing plans.
  • Q418 revenue of $338m was in line with the Jan. 7th preliminary announcement (“sales to exceed $331m,” BCM est. $288m).
  • Management reiterated sales guidance of 15-20% growth ($1.19-$1.24bn), and set a GM target of 65% with Adj. Op margin of 5.5%, and Adj. EBITDA of 18%.

Analysis and Comments

  • A newly announced restructuring initiative is incremental to forecasts and represents upside to future margin expansion prospects. This should help Dexcom drive leverage as it strives for the 2023 15% operating margin target set at the Dec. 2018 analyst day.
  • This is one of the leading companies in sectors linked to the diabetes value chain that are likely to benefit.

Published by Mr. Crypto Lemon

on


Posted from my blog with SteemPress : https://mentormarket.io/stocks/mr-crypto-lemon/dexco-diabete-medtech-company-is-delivering-on-its-promises/

#healthcare #steempress #stocks #timm
5 years ago in #dexcom by
$7.63
  • Past Payouts $7.63, 0.00 TRX
  • - Author $5.98, 0.00 TRX
  • - Curators $1.65, 0.00 TRX
139 votes
Reply 0

Coin Marketplace

STEEM 0.26
TRX 0.11
JST 0.033
BTC 64999.89
ETH 3101.81
USDT 1.00
SBD 3.87